PMDA — authorised 29 June 2020
- Marketing authorisation holder: Kyorin Pharmaceutical Co., Ltd.
- Status: approved
🇯🇵 Cutivate in Japan
PMDA authorised Cutivate on 29 June 2020
Marketing authorisation
Cutivate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Cutivate approved in Japan?
Yes. PMDA authorised it on 29 June 2020.
Who is the marketing authorisation holder for Cutivate in Japan?
Kyorin Pharmaceutical Co., Ltd. holds the Japanese marketing authorisation.